Atara biotherapeutics names cell therapy & oncology leader jakob dupont, m.d. as global head of research & development

Atara biotherapeutics, inc. (nasdaq: atra), a pioneer in t-cell immunotherapy leveraging its novel allogeneic ebv t-cell platform to develop transform

ATRA Ratings Summary

ATRA Quant Ranking